Home / Cancer and immune system / Thiotepa
ATC L01AC01 · Antineoplastic Agents
Thiotepa shortage
As of 31 Oct 2026, Thiotepa has a reported shortage in 2 of the 5 countries we track (Italy, Spain), covering 4 products.
Countries2/5
Products4packs or presentations
Short since15 Sep 20242.1 years ago
Earliest returnnot givencompany estimate
No return date4products
Main reasonManufacturing problem
Timeline
ItalySpain
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | THIOTEPA MEDAC | MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH | 15 Sep 2024 | not given | Manufacturing problem Problemi produttivi: forniture discontinue |
| IT | THIOTEPA MEDAC | MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH | 1 Oct 2024 | not given | Manufacturing problem Problemi produttivi: forniture discontinue |
| ES | TIOTEPA SEACROSS 100 MG POLVO PARA CONCETRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial | Seacross Pharma (Europe) Limited | 6 Oct 2026 | not given | Not stated |
| ES | TIOTEPA SEACROSS 15 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial | Seacross Pharma (Europe) Limited | 6 Oct 2026 | not given | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.